4//SEC Filing
Pronovost Peter 4
Accession 0001104659-21-075863
CIK 0000019446other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 5:27 PM ET
Size
6.3 KB
Accession
0001104659-21-075863
Insider Transaction Report
Form 4
Pronovost Peter
Director
Transactions
- Disposition to Issuer
Common Stock, par value $.10 per share
2021-06-02$80.59/sh−22,970.431$1,851,187→ 0 total
Footnotes (2)
- [F1]Represents shares that, at the effective time of the First Merger (as defined in the Agreement and Plan of Merger, as amended and restated on March 1, 2021 (the "Merger Agreement"), by and among Cantel Medical Corp., a Delaware corporation (the "Company"), STERIS plc, an Irish public limited company ("STERIS"), Solar New US Holding Co, LLC and Crystal Merger Sub 1, LLC) (the "Effective Time"), were converted into the right to receive (i) 0.33787 ordinary shares, par value $0.001 per share, of STERIS (the "Stock Consideration"), and (ii) $16.93 in cash (the "Cash Consideration" and, together with the Stock Consideration, the "Merger Consideration").
- [F2]Based on the closing price of ordinary shares of STERIS on June 1, 2021, the last trading day before the Effective Time, the value of the Stock Consideration payable per share of common stock, par value $.10 per share, of the Company ("Company Common Stock") was $63.66, and the value of the Merger Consideration payable per share of Company Common Stock pursuant to the Merger Agreement was $80.59.
Documents
Issuer
CANTEL MEDICAL CORP
CIK 0000019446
Entity typeother
Related Parties
1- filerCIK 0001511062
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 5:27 PM ET
- Size
- 6.3 KB